Chun Geun Lee Selected Research

kasugamycin

2/2022	Host Chitinase 3-like-1 is a Universal Therapeutic Target for SARS-CoV-2 Viral Variants in COVID 19.
1/2022	Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.
1/2022	Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun Geun Lee Research Topics

Disease

50	Inflammation (Inflammations) 01/2022 - 03/2002
25	Fibrosis (Cirrhosis) 01/2022 - 03/2002
22	Asthma (Bronchial Asthma) 01/2019 - 03/2003
14	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 08/2004
13	Pneumonia (Pneumonitis) 01/2019 - 03/2002
11	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 08/2006
10	Emphysema 07/2014 - 06/2005
9	Neoplasms (Cancer) 01/2022 - 11/2003
9	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2012
9	Metaplasia 06/2012 - 03/2002
7	COVID-19 02/2022 - 09/2020
6	Infections 02/2022 - 12/2010
6	Pulmonary Emphysema 01/2021 - 05/2005
5	Lung Diseases (Lung Disease) 01/2022 - 03/2007
5	Lung Injury 01/2016 - 04/2005
5	Respiratory Hypersensitivity 01/2012 - 10/2004
4	Melanoma (Melanoma, Malignant) 01/2016 - 05/2012
4	Vascular Remodeling 01/2013 - 10/2004
4	Hyperoxia 10/2010 - 08/2003
3	Idiopathic Pulmonary Fibrosis 01/2022 - 12/2012
3	Airway Remodeling 03/2016 - 09/2002
3	Virus Diseases (Viral Diseases) 12/2015 - 08/2008
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2015 - 03/2007
3	Edema (Dropsy) 11/2011 - 10/2004
3	Hyperplasia 11/2011 - 08/2003
3	Acute Lung Injury 10/2010 - 04/2005
3	Respiratory Insufficiency (Respiratory Failure) 02/2005 - 03/2002
2	Macrophage Activation Syndrome 01/2021 - 11/2020
2	Chronic Disease (Chronic Diseases) 11/2020 - 10/2019
2	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 01/2018 - 08/2015
2	Delayed Graft Function 01/2017 - 02/2013
2	Necrosis 02/2013 - 04/2005
2	Stomach Neoplasms (Stomach Cancer) 11/2007 - 11/2003
1	Alzheimer Disease (Alzheimer's Disease) 03/2022
1	Neuroinflammatory Diseases 03/2022
1	Delirium 01/2022

Drug/Important Bio-Agent (IBA)

36	ChitinasesIBA 02/2022 - 09/2005
26	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2005
19	CytokinesIBA 01/2021 - 03/2003
19	Interleukin-13IBA 01/2019 - 03/2002
11	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2010
11	AllergensIBA 11/2020 - 04/2007
10	SmokeIBA 12/2015 - 12/2005
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 10/2004
6	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 06/2005
6	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 08/2004
6	ChitinIBA 01/2018 - 12/2008
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 05/2007
5	OvalbuminIBA 11/2020 - 06/2010
5	Messenger RNA (mRNA)IBA 10/2019 - 09/2002
5	Oxidants (Oxidizing Agents)IBA 01/2016 - 04/2005
4	chitotriosidaseIBA 01/2021 - 05/2014
4	Immunoglobulin E (IgE)IBA 11/2020 - 12/2008
4	Small Interfering RNA (siRNA)IBA 01/2018 - 05/2007
4	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2015 - 12/2004
4	InterleukinsIBA 01/2013 - 09/2002
4	Interleukin-11 (Interleukin 11)IBA 12/2008 - 03/2003
3	kasugamycinIBA 02/2022 - 01/2022
3	indium-bleomycinIBA 01/2022 - 03/2007
3	LigandsIBA 11/2021 - 12/2012
3	Antiviral Agents (Antivirals)IBA 09/2020 - 05/2011
3	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2006
3	AmphiregulinIBA 03/2016 - 12/2012
3	Interleukin-18 (Interleukin 18)IBA 12/2015 - 02/2007
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2013 - 05/2007
3	Poly I-CIBA 11/2011 - 08/2008
3	ChemokinesIBA 01/2006 - 03/2002
2	Chitinase-3-Like Protein 1IBA 03/2022 - 01/2022
2	HydrolasesIBA 01/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2022 - 09/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2016
2	Oxygen (Dioxygen)IBA 01/2021 - 11/2020
2	CateninsIBA 01/2020 - 08/2013
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 08/2002
2	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 03/2016 - 01/2013
2	InflammasomesIBA 06/2015 - 08/2013
2	Semaphorins (Semaphorin)IBA 02/2015 - 05/2007
2	ErbB Receptors (EGF Receptor)IBA 05/2014 - 12/2012
2	Pathogen-Associated Molecular Pattern MoleculesIBA 09/2013 - 08/2008
2	MucinsIBA 05/2011 - 09/2002
2	Therapeutic UsesIBA 04/2011 - 04/2007
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2011 - 04/2007
2	aluminum sulfate (alum)IBA 12/2010 - 08/2010
2	Interleukin-4 (Interleukin 4)IBA 08/2010 - 05/2006
2	Biological ProductsIBA 05/2009 - 04/2007
2	AntigensIBA 12/2008 - 10/2004
2	Caspase 3 (Caspase-3)IBA 03/2008 - 06/2005
2	CathepsinsIBA 03/2007 - 02/2007
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2006 - 06/2005
2	Hyaluronic Acid (Hyaluronan)IBA 02/2005 - 03/2002
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2022
1	N 556IBA 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	CollagenIBA 01/2022
1	SpermidineIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022

Therapy/Procedure

3	Therapeutics 11/2021 - 05/2014
2	Transplantation 01/2022 - 02/2013